IOLCPNSEIOL Chemicals and Pharmaceuticals Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 21 May · 16:59 IST

IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

IOLCP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.8%1-day move
₹121.11
prior close
₹121.05
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-1.4-1.2-1.5+2.8+13.0+8.2+5.9+3.7+8.9+10.1+7.8+22.2
Up moveDown movePending
AI summary

IOL Chemicals published its audited Q4 and full year FY26 results. For the year ended March 31, 2026, total income was Rs 2,340.34 crore. Net profit after tax stood at Rs 99.63 crore (standalone). Basic and diluted EPS improved to Rs 4.69 compared to Rs 3.44 in the previous year, representing a 36% increase. For Q4 FY26 standalone, total income was Rs 621.19 crore with net profit after tax of Rs 53.18 crore and EPS of Rs 1.81. Results were reviewed by the Audit Committee and approved by the Board on May 20, 2026. The company published extracts in Business Standard, Financial Express, Economic Times and Punjabi Jagran.

Likely market impact

EPS growth of 36% year-on-year is a positive signal for shareholders, indicating improved profitability per share despite fluctuations in absolute profit figures. The stock may see a bullish reaction given the earnings per share improvement.